Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 12/20 | 0.53 |
| ▸ | WNT3A | P56704 | 1/20 | 0.47 |
| ▸ | SNCA | P37840 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SULT1A1 | P50225 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29764555 | 1.00 | APP (0.53) | APPWNT3ASNCAGLAGAA | |
| SCHEMBL2055250 | 0.85 | APP (0.71) | APPSNCAGLAGAASULT1A1 | |
| SCHEMBL23263904 | 0.84 | APP (0.53) | APPWNT3AGLAGAASULT1A1 | |
| SCHEMBL2055194 | 0.83 | APP (0.59) | APPSNCAGLAGAA | |
| SCHEMBL23327788 | 0.82 | APP (0.52) | APPWNT3AGLAGAASULT1A1 | |
| SCHEMBL2055187 | 0.82 | APP (0.58) | APPSNCAGLAGAA | |
| SCHEMBL2055226 | 0.82 | APP (0.74) | APPWNT3ASNCAGLAGAA | |
| SCHEMBL21469221 | 0.81 | APP (0.50) | APPWNT3AGLAGAA | |
| SCHEMBL5117916 | 0.81 | APP (0.56) | APPSNCAGLAGAASULT1A1 | |
| SCHEMBL23246219 | 0.80 | APP (0.51) | APPWNT3AGLAGAASULT1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240165276-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | CBD SOLUTIONS AB (SE) | 2024-05-23 | — | — | US | claimed |
| EP-4045495-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | Karin & Sten Mortstedt CBD Solutions AB (SE) | 2022-08-24 | — | — | EP | claimed |
| WO-2021074351-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | KARIN & STEN MORTSTEDT CBD SOLUTIONS AB (SE) | 2021-04-22 | — | — | WO | claimed |
| US-20240165276-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | CBD SOLUTIONS AB (SE) | 2024-05-23 | — | — | US | disclosed |
| EP-4045495-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | Karin & Sten Mortstedt CBD Solutions AB (SE) | 2022-08-24 | — | — | EP | disclosed |
| WO-2021074351-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | KARIN & STEN MORTSTEDT CBD SOLUTIONS AB (SE) | 2021-04-22 | — | — | WO | disclosed |
| WO-2021074351-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | KARIN & STEN MORTSTEDT CBD SOLUTIONS AB (SE) | 2021-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240165276-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | MAPT, FUS, PSEN1 | APP 4/4885WNT3A 4173/4885SNCA 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.